Management of Atrial Arrhythmias After Lung Transplant
JACC: Clinical Electrophysiology · 2023-08 · 9 (8) · 1824-1835
DOI: 10.1016/j.jacep.2023.01.021 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift JACC: Clinical Electrophysiology, 2023-08. Verfasst von Jacopo Marazzato und 2 weiteren Autor:innen. Beteiligte Einrichtung: Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA; Departm…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Lung Transplantation, Amiodarone. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
The overall survival in patients undergoing lung transplantation is poor. Although postsurgical atrial arrhythmias seem to play a major role in the morbidity and mortality of this population, data regarding the clinical and interventional management of this complication are still controversial. Through a review of the literature in the field, we observed that not only the surgical technique is clearly arrhythmogenic, but the new administration of peri-procedure beta-blockers and amiodarone for arrhythmia prevention and treatment, respectively, seems harmful in these postsurgical patients. However, low-dose beta-blockers administered after surgery seem feasible in arrhythmia prevention in specific patient subgroups, and, aside from amiodarone, alternative antiarrhythmic agents can be safely and effectively used to treat symptomatic patients on top of adequate rate control. Finally, as to complex atrial arrhythmias occurring late after lung transplant surgery, radiofrequency catheter ablation seems a feasible treatment option. In light of this evidence and considering the absence of clear recommendations in the field, we suggest a practical approach that may help the clinician in the management of this postsurgical complication. However, as most of these considerations are drawn from small-sized and retrospective studies, more evidence is needed in the future to clarify which medical and interventional strategies may best treat these postsurgical arrhythmias and thus potentially improve the outcome of these frail patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA; Department of Medicine and Surgery, University of Insubria, Varese, Italy.
- Department of Anesthesiology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, USA; Klinik für Anästhesiologie und Intensivmedizin, Universität Duisburg-Essen, Essen, Germany.
- Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA. Electronic address: dibbia@gmail.org.
Zitieren
APA
Marazzato, J., Eikermann, M., & Di Biase, L. (2023). Management of Atrial Arrhythmias After Lung Transplant. JACC: Clinical Electrophysiology, 9(8), 1824-1835. https://doi.org/10.1016/j.jacep.2023.01.021
Vancouver
Marazzato J, Eikermann M, Di Biase L. Management of Atrial Arrhythmias After Lung Transplant. JACC: Clinical Electrophysiology. 2023;9(8):1824-1835. doi:10.1016/j.jacep.2023.01.021
BibTeX
@article{Marazzato2023,
author = {Marazzato, Jacopo and Eikermann, Matthias and Di Biase, Luigi},
title = {Management of Atrial Arrhythmias After Lung Transplant},
journal = {JACC: Clinical Electrophysiology},
year = {2023},
volume = {9},
number = {8},
pages = {1824--1835},
doi = {10.1016/j.jacep.2023.01.021}
}
EUVIMED